Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions
T-cell lymphomas are a relatively rare group of malignancies with a diverse range of pathologic features and clinical behaviors. Recent molecular studies have revealed a wide array of different mechanisms that drive the development of these malignancies and may be associated with resistance to thera...
Guardado en:
Autores principales: | Maliha Khan, Felipe Samaniego, Fredrick B. Hagemeister, Swaminathan P. Iyer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0350a11afc3c432e9a8a4dcf33f96c59 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Update on Novel Therapeutics for Primary CNS Lymphoma
por: Lauren R. Schaff, et al.
Publicado: (2021) -
Linfoma relacionado a infección por virus de la inmunodeficiencia humana en un hospital público de Santiago, Chile
por: Cabrera,María Elena, et al.
Publicado: (2012) -
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma
por: Alvaro J. Alencar, et al.
Publicado: (2021) -
Evolución de un linfoma no Hodgkin “triple expresor” en un paciente trasplantado renal con quimioterapia DA-R-EPOCH. Caso clínico
por: Aránguiz,Natalia, et al.
Publicado: (2019) -
FEATURES OF THE CUMULATIVE INCIDENCE OF LYMPHOMAS IN DIFFERENT REGIONS OF THE CHERKASY REGION
por: V.V. Paramonov, et al.
Publicado: (2021)